News and Views
Nature Medicine 14, 1152 - 1153 (2008)
doi:10.1038/nm1108-1152
RIG-ing an antitumor response
Fabio Petrocca1 & Judy Lieberman1
-
Fabio Petrocca and Judy Lieberman are at the Immune Disease Institute and Department of Pediatrics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts, 02115, USA.
e-mail: lieberman@idi.harvard.edu
Abstract
A small interfering RNA has been engineered to silence an oncogene and activate the immune response simultaneously. The approach shrinks tumors in mice (pages 1256–1263).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
RNA interference below the immune radarNature Biotechnology News and Views (01 May 2006)
Sensing RNA virus infectionsNature Chemical Biology News and Views (01 Jan 2007)
See all 11 matches for News And ViewsRESEARCH
Drug Delivery?mediated Control of RNA ImmunostimulationMolecular Therapy Original Article
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanomaNature Medicine Article (01 Nov 2008)
See all 20 matches for Research
